PRESS RELEASE published on 01/30/2025 at 18:00, 1 year 1 month ago THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2024 AND PRESENTS ITS PROGRESS REPORT Theranexus announces cash position of €4.0 M as of 29 January 2025, strengthening financial outlook. Biopharmaceutical company progressing on rare neurological disease treatments, including Niemann-Pick and Gaucher diseases Cash Position Biopharmaceutical Financial Outlook Theranexus Neurological Diseases
BRIEF published on 01/23/2025 at 18:20, 1 year 1 month ago Theranexus Unveils 2025 Financial Calendar Financial Calendar Biopharmaceutical Theranexus Neurological Diseases 2025 Schedule
PRESS RELEASE published on 01/23/2025 at 18:15, 1 year 1 month ago THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025 Theranexus, a biopharmaceutical company in rare neurological disease treatment, announces its 2025 financial communication agenda for Euronext market. Dates subject to change Euronext Biopharmaceutical Financial Communication Theranexus Neurological Diseases
BRIEF published on 01/23/2025 at 18:05, 1 year 1 month ago Theranexus Announces its Financial Agenda for 2025 Euronext Paris Financial Agenda Theranexus Financial Publications Neurological Diseases
BRIEF published on 01/16/2025 at 18:05, 1 year 2 months ago Theranexus: Monthly update of voting rights and shares Voting Rights Actions Stock Market Biopharmaceutical Theranexus
BRIEF published on 01/09/2025 at 18:05, 1 year 2 months ago Theranexus Publishes its Letter to Shareholders Financial Outlook Theranexus Rare Neurological Diseases Letter To Shareholders Innovative Platform
PRESS RELEASE published on 01/09/2025 at 18:00, 1 year 2 months ago THERANEXUS ANNOUNCES THE PUBLICATION OF ITS LETTER TO SHAREHOLDERS Theranexus, an innovative biopharmaceutical company, announces the publication of its letter to shareholders. Shareholders can download the newsletter from the company website Shareholders Biopharmaceutical Newsletter Theranexus Neurological Diseases
BRIEF published on 12/17/2024 at 18:20, 1 year 3 months ago Theranexus optimizes its cash flow and extends its financial horizon Treasury Funding License Agreement Theranexus Batten Disease
PRESS RELEASE published on 12/17/2024 at 18:15, 1 year 3 months ago THERANEXUS PRESENTS AN UPDATE OF ITS CASH POSITION AND FINANCING HORIZON Theranexus presents an update of its cash position and cash flow horizon, expecting improvement through upcoming payments and restructuring agreement with banking partners Cash Position Cash Flow Financial Debt Theranexus Banking Partners
BRIEF published on 12/17/2024 at 18:05, 1 year 3 months ago License agreement between Theranexus and Exeltis for TX01 Rare Diseases License Agreement Theranexus Exeltis TX01
Published on 03/19/2026 at 13:50, 12 minutes ago Predictiv AI Appoints Multi-Agent Systems Pioneer Professor George Rzevski as Strategic Advisor to Advance Swarm AI Platforms
Published on 03/19/2026 at 13:30, 32 minutes ago Hillcrest Energy Technologies CEO Don Currie Discusses ZVS Technology and Commercialization Progress in Stocks To Watch Investor Interview
Published on 03/19/2026 at 13:30, 32 minutes ago ACCESS Newswire Reports Fourth Quarter and Full Year 2025 Results
Published on 03/19/2026 at 13:15, 47 minutes ago Worksport Presents New Premium "Game Changer" Tonneau Cover Model to Industry Buyers at Keystone BIG Show; Initiates Pre-Orders Ahead of Near-Term Commercial Launch
Published on 03/19/2026 at 13:10, 52 minutes ago Adcore to Publish Fourth Quarter and 2025 Year End Results on March 26th, 2026
Published on 03/19/2026 at 13:43, 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 03/19/2026 at 13:40, 22 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 03/19/2026 at 13:10, 51 minutes ago DCK Showcases Expanded Professional Power Tool and Outdoor Power Equipment Portfolio at EISENWARENMESSE 2026, Strengthening European Market Commitment
Published on 03/19/2026 at 08:45, 5 hours 17 minutes ago Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 7 hours 2 minutes ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 7 hours 2 minutes ago 2025 Annual results and new strategic signature
Published on 03/18/2026 at 19:41, 18 hours 20 minutes ago Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 20 hours 2 minutes ago Deezer achieves profitability in FY25 as strategy delivers tangible results
